Gregory Duncan's Insider Trades & SAST Disclosures

Gregory Duncan's most recent trade in CorMedix Inc was a trade of 25,000 Common Stock done . Disclosure was reported to the exchange on Jan. 17, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
CorMedix Inc
Gregory Duncan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2025 25,000 25,000 (0%) 0% 0 Common Stock
CorMedix Inc
Gregory Duncan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2024 30,000 30,000 - - Stock Option (Right to Buy Common Stock)
Dogwood Therapeutics Inc.
Gregory Duncan Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2024 138,835 138,835 - - Stock Option (right to buy)
Dogwood Therapeutics Inc.
Gregory Duncan Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 1.25 per share. 17 Aug 2023 25,000 57,461 - 1.2 31,245 Common Stock
CorMedix Inc
Gregory Duncan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2023 20,000 20,000 - - Stock Option (Right to Buy Common Stock)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades